US FDA-cleared ComASP®

The following materials are valid only for users based in the United States or subjected to the US FDA regulations on in-vitro diagnostics (IVD) devices.

e-IFU latest revision 510(k) Substantial Equivalence Determination
Decision Summary
ComASP Cefiderocol 0.008-128 (US version) rev.0 - 05/2023

Request Quote or Information